Literature DB >> 26763885

BMI1 Regulation of Self-Renewal and Multipotency in Human Mesenchymal Stem Cells.

Yunjoon Jung, Jan A Nolta1.   

Abstract

We have previously described generation of mesenchymal stem cells (MSCs) from human embryonic and induced pluripotent stem cells. One of the central questions in stem cell biology is to understand how stem cells regulate the decision to self-renew vs. differentiate, at the molecular level. In the current studies we used loss-of-function and gain-of-function analyses in primary human MSCs to demonstrate that BMI1 is a critical regulator for self-renewal and multipotency in this interesting cell type. Knockdown of BMI1 in MSCs reduced self-renewal by upregulation of p16(INK4A) and increased apoptosis. Knockdown of p16(INK4A) partially rescued the self-renewal defect in MSCs with loss of BMI1. Overexpressed BMI1 reduced apoptosis and increased cell proliferation by repressing p16(INK4A). Loss of BMI1 resulted in deregulation of PPARγ, an adipogenic factor, and imprinted gene network (IGN), which blocks osteogenesis. Knockdown of PPARγ or IGN in BMI1 defect models restored osteogenesis. Overexpression of BMI1 repressed transcripts of RUNX2 and PPARγ, in osteogenesis and adipogenesis, respectively, which lead to decreased lineage specification potential in MSCs. These data show that BMI1 regulates cell proliferation, apoptosis, and differentiation of human MSCs.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26763885      PMCID: PMC9491491          DOI: 10.2174/1574888x1102160107171432

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.758


  48 in total

Review 1.  Polycomb silencing mechanisms and the management of genomic programmes.

Authors:  Yuri B Schwartz; Vincenzo Pirrotta
Journal:  Nat Rev Genet       Date:  2007-01       Impact factor: 53.242

2.  Lung stem cell self-renewal relies on BMI1-dependent control of expression at imprinted loci.

Authors:  Sima J Zacharek; Christine M Fillmore; Allison N Lau; David W Gludish; Alan Chou; Joshua W K Ho; Raffaella Zamponi; Roi Gazit; Christoph Bock; Natalie Jäger; Zachary D Smith; Tae-min Kim; Arven H Saunders; Janice Wong; Joo-Hyeon Lee; Rebecca R Roach; Derrick J Rossi; Alex Meissner; Alexander A Gimelbrant; Peter J Park; Carla F Kim
Journal:  Cell Stem Cell       Date:  2011-09-02       Impact factor: 24.633

3.  Characterization and in vivo testing of mesenchymal stem cells derived from human embryonic stem cells.

Authors:  William Gruenloh; Amal Kambal; Claus Sondergaard; Jeannine McGee; Catherine Nacey; Stefanos Kalomoiris; Karen Pepper; Scott Olson; Fernando Fierro; Jan A Nolta
Journal:  Tissue Eng Part A       Date:  2011-03-04       Impact factor: 3.845

Review 4.  Silencing chromatin: comparing modes and mechanisms.

Authors:  Christian Beisel; Renato Paro
Journal:  Nat Rev Genet       Date:  2011-01-11       Impact factor: 53.242

5.  E4F1: a novel candidate factor for mediating BMI1 function in primitive hematopoietic cells.

Authors:  Jalila Chagraoui; Sherry L Niessen; Julie Lessard; Simon Girard; Philippe Coulombe; Martin Sauvageau; Sylvain Meloche; Guy Sauvageau
Journal:  Genes Dev       Date:  2006-08-01       Impact factor: 11.361

6.  Effects and safety of allogenic mesenchymal stem cell intravenous infusion in active ankylosing spondylitis patients who failed NSAIDs: a 20-week clinical trial.

Authors:  Peng Wang; Yuxi Li; Lin Huang; Jiewen Yang; Rui Yang; Wen Deng; Biling Liang; Lie Dai; Qingqi Meng; Liangbin Gao; Xiaodong Chen; Jun Shen; Yong Tang; Xin Zhang; Jingyi Hou; Jichao Ye; Keng Chen; Zhaopeng Cai; Yanfeng Wu; Huiyong Shen
Journal:  Cell Transplant       Date:  2013-05-22       Impact factor: 4.064

7.  Defects in mesenchymal stem cell self-renewal and cell fate determination lead to an osteopenic phenotype in Bmi-1 null mice.

Authors:  Heng-Wei Zhang; Jiong Ding; Jian-Liang Jin; Jian Guo; Jing-Ning Liu; Andrew Karaplis; David Goltzman; Dengshun Miao
Journal:  J Bone Miner Res       Date:  2010-03       Impact factor: 6.741

8.  shRNA knockdown of Bmi-1 reveals a critical role for p21-Rb pathway in NSC self-renewal during development.

Authors:  Christopher A Fasano; John T Dimos; Natalia B Ivanova; Natalia Lowry; Ihor R Lemischka; Sally Temple
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

9.  PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells.

Authors:  Keith R Shockley; Oxana P Lazarenko; Piotr J Czernik; Clifford J Rosen; Gary A Churchill; Beata Lecka-Czernik
Journal:  J Cell Biochem       Date:  2009-02-01       Impact factor: 4.429

10.  A clinical trial report of autologous bone marrow-derived mesenchymal stem cell transplantation in patients with spinal cord injury.

Authors:  Pu-Cha Jiang; Wen-Ping Xiong; Ge Wang; Chao Ma; Wei-Qi Yao; Steven F Kendell; Brian M Mehling; Xian-Hou Yuan; Dong-Cheng Wu
Journal:  Exp Ther Med       Date:  2013-04-29       Impact factor: 2.447

View more
  3 in total

Review 1.  Epigenetic-Based Mechanisms of Osteoblast Suppression in Multiple Myeloma Bone Disease.

Authors:  Juraj Adamik; G David Roodman; Deborah L Galson
Journal:  JBMR Plus       Date:  2019-03-15

2.  Isolation and Characterization of Human Suture Mesenchymal Stem Cells In Vitro.

Authors:  Liangliang Kong; Yuan Wang; Yi Ji; Jianbing Chen; Jie Cui; Weimin Shen
Journal:  Int J Stem Cells       Date:  2020-11-30       Impact factor: 2.500

Review 3.  Epigenetics in Prader-Willi Syndrome.

Authors:  Aron Judd P Mendiola; Janine M LaSalle
Journal:  Front Genet       Date:  2021-02-15       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.